Endoscopy, Table of Contents Endoscopy 2013; 45(S 02): E86-E87DOI: 10.1055/s-0032-1326258 Cases and Techniques Library (CTL) © Georg Thieme Verlag KG Stuttgart · New York Use of hemostatic powder (Hemospray) in the management of refractory gastric variceal hemorrhage A. J. Stanley Gastrointestinal Unit, Glasgow Royal Infirmary, Glasgow, UK , L. A. Smith Gastrointestinal Unit, Glasgow Royal Infirmary, Glasgow, UK , A. J. Morris Gastrointestinal Unit, Glasgow Royal Infirmary, Glasgow, UK › Author Affiliations Recommend Article Abstract Full Text References References 1 Holster IL, De Maat MP, Ducharme R et al. In vitro examination of the effects of the hemostatic powder (hemospray) on coagulation and thrombus formation in humans. Gastrointest Endosc 2012; 75: AB240 2 Giday SA, Kim Y, Krishnamurty DM et al. Long-term randomized controlled trial of a novel nanopowder hemostatic agent (TC-325) for control of severe arterial upper gastrointestinal bleeding in a porcine model. Endoscopy 2011; 4: 296-299 3 Sung JJ, Luo D, Wu JC et al. Early clinical experience of the safety and effectiveness of Hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 2011; 43: 291-295 4 Chen YI, Barkun AN, Soulellis C et al. Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc 2012; 75: 1278-1281 5 Smith LA, Stanley AJ, Morris AJ. Hemospray for non-variceal upper gastrointestinal bleeding: results of the SEAL dataset (survey to evaluate the application of hemospray in the luminal tract). Gut 2012; 61: A61-A62
